Concorde Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $765K | Buy |
|
|||||
|
2024
Q4 | $695K | Sell |
|
|||||
|
2024
Q3 | $980K | Sell |
|
|||||
|
2024
Q2 | $1.01M | Buy |
|
|||||
|
2024
Q1 | $760K | Buy |
|
|||||
|
2023
Q4 | $557K | Sell |
|
|||||
|
2023
Q3 | $563K | Buy |
|
|||||
|
2023
Q2 | $475K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $369K | Sell |
|
|||||
|
2022
Q3 | $327K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $279K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $214K | Buy |
|
|||||
|
2021
Q2 | $203K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $221K | Sell |
|
|||||
|
2015
Q1 | $230K | Buy |
|
|||||
|
2014
Q4 | $207K | Buy |
|